This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Acute Kidney Injury, Cardiac Disease or Surgery
and you are
between 18 and 80
years old
-
The phase for this study is not defined.
Show me locations

The purpose

To testify the prevention of Erythropoietin on cardiac surgery associated-acute kidney injury, and trying to provide evidence for protecting the renal function and improving the prognosis for patients after cardiac surgery.

Provided treatments

  • Drug: Erythropoietin
  • Drug: 0.9% sodium chloride
  • Procedure: cardiac surgery

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03007537. The sponsor of the trial is Nanjing First Hospital, Nanjing Medical University and it is looking for 101 volunteers for the current phase.
Official trial title:
The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury